ArticleAdvances in therapy2026

Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis.

Lytske J Bakker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.